Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BOrient Pharma Co., Ltd. 〉Multi-day Transdermal Drug Delivery (MTDD)

Multi-day Transdermal Drug Delivery (MTDD)

Multi-day Transdermal Drug Delivery (MTDD)

Orient Pharma's MTDD demonstrates the strengths of non-oral use for elderly patients, patients with neural disorders who have difficulty in swallowing, andt ensures the stability of blood concentration, high compliance and convenience of medical care.

Request for Collaboration
Overview
Matrix type of design resolves API to form API/Adhesive patch, which is embedded in between Backing Layer and Release Liner. The API containing side of the patch can be adhered to the skin by tearing off the Release Liner. The patch can be designed as double layers for 1-2 days use or single layer for multiple days use.
Application
Orient Pharma technically transferred the patch product for treating Alzeheimer's disease to Beijing TidePharma to target US and China market.
Collaboration Options
Open for global collaboration
People who like this also like
  • FB704AFB704A
  • SB05SB05
  • Multi-day Transdermal Drug Delivery (MTDD)Multi-day Transdermal Drug Delivery (MTDD)
  • SNP-610SNP-610
  • PipelinePipeline
  • Applying next generation sequencing in preimplantation genetic screeningApplying next generation sequencing in preimplantation genetic screening
  • TLC399TLC399
  • PixoTest technologyPixoTest technology
  • Dual-targeted bifunctional anti-flu drug (CHO-S05)Dual-targeted bifunctional anti-flu drug (CHO-S05)
  • Multiple-Phasic Release Technology (MPRT)Multiple-Phasic Release Technology (MPRT)